08/31/2026
BPC-157 and TB-500 just left the biohacking corners of the internet.
An FDA advisory panel voted to recommend them for compounding access, along with KPV, MOTS-c, Epitalon, and Semax.
That does not mean they are approved drugs.
It means the most talked-about peptides in recovery culture are now in official regulatory conversation.
The next 12 months in this space are going to get loud.
Kits4Less: kits4less.is